Advertisement

Virtual screening by molecular docking

  • Didier Rognan
Chapter

Abstract

The growing number of genomic targets of therapeutic interest (HOPKINS and GROOM, 2002) and macromolecules (proteins, nucleic acids) for which a threedimensional structure (3D) is available (BERMAN et al., 2000) makes the techniques of virtual screening increasingly attractive for projects aiming to identify bioactive molecules (WALTERS et al., 1998; LENGAUER et al., 2004).

Keywords

Nucleic Acid Molecular Docking Virtual Screening Bioactive Molecule Genomic Target 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. BAURIN N., BAKER R., RICHARDSON C., CHEN I., FOLOPPE N., POTTER A., JORDAN A., ROUGHLEY S., PARRATT M., GREANEY P., MORLEY D., HUBBARD R.E. (2004) Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds. J. Chem. Inf. Comput. Sci. 44: 643-651Google Scholar
  2. BECKER O.M., MARANTZ Y., SHACHAM S., INBAL B., HEIFETZ A., KALID O., BAR-HAIM S., WARSHAVIAK D., FICHMAN M., NOIMAN S. (2004) G protein-coupled receptors: in silico drug discovery in 3D. Proc. Natl Acad. Sci. USA 101: 11304-11309CrossRefGoogle Scholar
  3. BERMAN H.M., WESTBROOK J., FENG Z., GILLILAND G., BHAT T.N., WEISSIG H., SHINDYALOV I.N., BOURNE P.E. (2000) The Protein Data Bank. Nucleic Acids Res. 28: 235-242CrossRefGoogle Scholar
  4. BISSANTZ C., FOLKERS G., ROGNAN D. (2000) Protein-based virtual screening of chemical databases. 1. Evaluation of different docking/scoring combinations. J. Med. Chem. 43: 4759-4767CrossRefGoogle Scholar
  5. BISSANTZ C., BERNARD P., HIBERT M., ROGNAN D. (2003) Protein-based virtual screening of chemical databases. II. Are homology models of G Protein-Coupled Receptors suitable targets? Proteins 50: 5-25CrossRefGoogle Scholar
  6. BRESSI, J.C., VERLINDE C.L., ARONOV A.M., SHAW M.L., SHIN S.S., NGUYEN L.N., SURESH S., BUCKNER F.S., VAN VOORHIS W.C., KUNTZ I.D., HOL W.G., GELB M.H. (2001) Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. J. Med. Chem. 44: 2080-2093CrossRefGoogle Scholar
  7. CHARIFSON P.S., CORKERY J.J., MURCKO M.A., WALTERS W.P. (1999) Consensus scoring: a method for obtaining improved hit rates from docking databases of three-dimensional structures into proteins. J. Med. Chem. 42: 5100-5109CrossRefGoogle Scholar
  8. CHARIFSON P.S., WALTERS W.P. (2002) Filtering databases and chemical libraries. J. Comput. Aided Mol. Des. 16: 311-323CrossRefGoogle Scholar
  9. DOMAN T.N., MCGOVERN S.L., WITHERBEE B.J., KASTEN T.P., KURUMBAIL R., STALLINGS W.C., CONNOLLY D.T., SHOICHET B.K. (2002) Molecular docking and high-throughput screening for novel inhibitors of protein tyrosine phosphatase-1B. J. Med. Chem. 45: 2213-2221CrossRefGoogle Scholar
  10. ENYEDY I.J., LING Y., NACRO K., TOMITA Y., WU X., CAO Y., GUO R., LI B., ZHU X., HUANG Y., LONG Y.Q., ROLLER P.P., YANG D., WANG S. (2001) Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening. J. Med. Chem. 44: 4313-4324CrossRefGoogle Scholar
  11. EVERS A., KLEBE G. (2004) Successful virtual screening for a submicromolar antagonist of the neurokinin-1 receptor based on a ligand-supported homology model. J. Med. Chem. 47: 5381-5392CrossRefGoogle Scholar
  12. FERRARA P., GOLHKE H., PRICE D.J., KLEBE G., BROOKS C.L. (2004) Assessing scoring functions for protein-ligand interactions. J. Med. Chem. 47: 3032-3047CrossRefGoogle Scholar
  13. FOLOPPE N., CHEN I.J., DAVIS B., HOLD A., MORLEY D., HOWES R. (2004) A structure-base strategy to identify new molecular scaffolds targeting the bacterial ribsome A-site. Bioorg. Med. Chem. 12: 935-947CrossRefGoogle Scholar
  14. GOHLKE H., KLEBE G. (2001) Statistical potentials and scoring functions applied to protein-ligand binding. Curr. Opin. Struct. Biol. 11: 231-235CrossRefGoogle Scholar
  15. GOULDSON P.R., KIDLEY N.J., BYWATER R.P., PSAROUDAKIS G., BROOKS H.D., DIAZ C., SHIRE D., REYNOLDS C.A. (2004) Toward the active conformations of rhodopsin and the beta2-adrenergic receptor. Proteins 56: 67-84CrossRefGoogle Scholar
  16. GRÜNEBERG S., WENDT B., KLEBE G. (2001) Subnanomolar inhibitors from computer screening: a model study using human carbonic anhydrase II. Angew Chem. Int. Ed. Engl. 40: 389-393CrossRefGoogle Scholar
  17. HOPKINS A.L., GROOM C.R. (2002) The druggable genome. Nat. Rev. Drug Discov. 1: 727-30CrossRefGoogle Scholar
  18. KELLENBERGER E., RODRIGO J., MULLER P., ROGNAN D. (2004) Comparative evaluation of eight docking tools for docking and virtual screening accuracy. Proteins 57: 225-242CrossRefGoogle Scholar
  19. KONTOYIANNI M., MCCLELLAN L.M., SOKOL G.S. (2004) Evaluation of docking performance: comparative data on docking algorithms. J. Med. Chem. 47: 558-565CrossRefGoogle Scholar
  20. KRAEMER O., HAZMANN I., PODJARNY A.D., KLEBE G. (2004) Virtual screening for inhibitors of human aldose reductase. Proteins 55: 814-823CrossRefGoogle Scholar
  21. LENGAUER T., LEMMEN C., RAREY M., ZIMMERMANN M. (2004) Novel technologies for virtual screening. Drug Discov. Today 9: 27-34CrossRefGoogle Scholar
  22. LYNE P.D., KENNY P.W., COSGROVE D.A., DENG C., ZABLUDOFF S., VENDOLOSKI J.J., ASHWELL S. (2004) Identification of compounds with nanomolar binding affinity for checkpoint kinase 1 using knowledge-based virtual screening. J. Med. Chem. 47: 1962-68CrossRefGoogle Scholar
  23. NICOLAOU C.A., TAMURA S.Y., KELLEY B.P., BASSETT S.I., NUTT R.F. (2002) Analysis of large screening data sets via adaptively grown phylogenetic-like trees. J. Chem. Inf. Comput. Sci. 42: 1069-1079Google Scholar
  24. NIKOLOVSKA-COLESKA Z., XU L., HU Z., TOMITA Y., LI P., ROLLER P.P., WANG R., FANG X., GUO R., ZHANG M., LIPPMAN M.E., YANG D., WANG S. (2004) Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J. Med. Chem. 47: 2430-2440CrossRefGoogle Scholar
  25. OSHIRO C., BRADLEY E.K., EKSTEROWICZ J., EVENSEN E., LAMB M.L., LANCTOT J.K., PUTTA S., STANTON R., GROOTENHUIS P.D. (2004) Performance of 3D-database molecular docking studies into homology models. J. Med. Chem. 47: 764-767CrossRefGoogle Scholar
  26. PAUL N., ROGNAN D. (2002) ConsDock: a new program for the consensus analysis of protein ligand interactions. Proteins 47: 521-533CrossRefGoogle Scholar
  27. PENG H., HUANG N., QI J., XIE P., XU C., WANG J., WANG C. (2003) Identification of novel inhibitors of BCR-ABL tyrosine kinase via virtual screening. Bioorg. Med. Chem. Lett. 13: 3693-3699CrossRefGoogle Scholar
  28. POWERS R.A., MORANDI F., SHOICHET B.K. (2002) Structure-based discovery of a novel, noncovalent inhibitor of AmpC beta-lactamase. Structure 10: 1013-1023CrossRefGoogle Scholar
  29. SHERIDAN R.P., SHPUNGIN J. (2004) Calculating similarities between biological activities in the MDL Drug Data Report database. J. Chem. Inf. Comput. Sci. 44: 727-740Google Scholar
  30. STAHL M., BÖHM H.J. (1998) Development of filter functions for protein-ligand docking. J. Mol. Graph. Model. 16: 121-132CrossRefGoogle Scholar
  31. TAYLOR R.D., JEWSBURY P.J., ESSEX J.W. (2002) A review of protein-small molecule docking methods. J. Comput. Aided Mol. Des. 16: 151-166CrossRefGoogle Scholar
  32. TAYLOR R.D., JEWSBURY P.J., ESSEX J.W. (2003) FDS: flexible ligand and receptor docking with a continuum solvent model and soft-core energy function. J. Comput. Chem. 24: 1637-1656CrossRefGoogle Scholar
  33. VIGERS G.P., RIZZI J.P. (2004) Multiple active site corrections for docking and virtual screening. J. Med. Chem. 47: 80-89CrossRefGoogle Scholar
  34. WALTERS W.P., STAHL M.T., MURCKO M.A. (1998) Virtual screening – an overview. Drug Discov. Today 3: 160-178CrossRefGoogle Scholar
  35. WASZKOWYCZ B., PERLINS T.D.J., SYKES R.A., LI J. (2001) Large-scale virtual screening for discovery leads in the postgenomic era. IBM Sys. J. 40: 361-376CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2011

Authors and Affiliations

  • Didier Rognan
    • 1
  1. 1.Laboratory of Therapeutical InnovationCNRS - Louis Pasteur University of StrasbourgStrasbourgFrance

Personalised recommendations